What Is the Best Binder for Biotoxin, Mold, and Mycotoxin Illness?

One of the most common questions patients ask us is deceptively simple:

“What is the best binder for mold toxins?”

It is a great question. Unfortunately, the answer is not as simple as many articles — or social media posts — would have you believe.

In recent years there has been a growing tendency within the mold-illness community to recommend a single binder, usually cholestyramine (CSM), as though it were the answer for every patient. Cholestyramine is undoubtedly one of the most powerful and best-studied prescription binders available. But that viewpoint oversimplifies both the chemistry of toxins and the complexity of the people we treat.

Over many years of practicing functional medicine, we have cared for patients with mold illness, Chronic Inflammatory Response Syndrome (CIRS), Lyme disease, Bartonella, long COVID, heavy-metal toxicity, persistent organic pollutants, and complex gastrointestinal disorders. One lesson has become increasingly clear:

Different toxins have different chemistry. Different patients have different physiology. So different binders serve different purposes.

Our goal is not to find the strongest binder. Our goal is to find the right binder — or the right combination of binders — for the person in front of us, and one they can actually tolerate long enough to heal.

Where Binders Fit: Step Two of the Shoemaker Protocol

Before we get into chemistry, it helps to know where binders sit in the bigger picture. In Dr. Ritchie Shoemaker’s original CIRS protocol, the sequence is deliberate. Step one is removal from exposure — getting out of the water-damaged building or eliminating the ongoing source of toxin. Step two is binding — using a binder to interrupt the recirculation of biotoxins and carry them out of the body. Binding while still exposed, as we tell patients, is like bailing out a boat without first plugging the hole.

These first two steps sound simple, but they are precisely where patients get stuck — sometimes for months, often for years. Finding and escaping the exposure can be genuinely difficult, and finding a binder (or combination) that a sensitive patient can actually tolerate is its own challenge. Most of this article lives inside step two, because getting it right is often what unlocks the rest of a person’s recovery.

It Starts With Chemistry

One of the biggest misconceptions in environmental medicine is that all binders work the same way. They don’t. Most binders work through completely different chemical mechanisms — some through anion exchange, others through cation exchange, and others through surface adsorption, hydrogen bonding, hydrophobic interactions, or even redox chemistry.

Just as importantly, not all toxins behave the same. Ochratoxin A behaves very differently than aflatoxin. Zearalenone behaves differently than gliotoxin. Heavy metals behave differently than PFAS. Persistent organic pollutants behave differently than bacterial endotoxins. Each has a different molecular weight, a different electrical charge, different fat solubility, different protein binding, and different routes of elimination.

If the chemistry of the toxin changes, the chemistry of the ideal binder often changes too. That single idea is the thread that runs through this entire article.

It’s Really About Biotoxins, Not Just Mold

Here is a reframe that changes everything. When we say “mold illness,” the real driver in Chronic Inflammatory Response Syndrome (CIRS) is rarely mold alone. A water-damaged building produces a whole soup of biotoxins, and Dr. Shoemaker’s research — using GENIE transcriptomic (gene-expression) testing and NeuroQuant brain-volume imaging — found that several non-mold biotoxins are often more inflammatory than the mycotoxins themselves. Chief among them: actinomycetes, endotoxins, and beta-glucans.

Actinomycetes (actinobacteria). These are gram-positive bacteria — species like Streptomyces — that thrive in the very same damp materials as mold. They produce potent inflammatory and mitochondrial toxins (such as valinomycin), and in laboratory studies they can be stronger inducers of inflammation than fungi.¹⁹ Importantly, many of their toxins are lipid-soluble, which is exactly the kind of compound cholestyramine is good at grabbing. For a deeper dive, see our article on actinomycetes and CIRS.

Endotoxins (LPS). These come from the cell walls of gram-negative bacteria and are powerfully pro-inflammatory. Endotoxin reaches us from two directions: from within, when a dysbiotic or leaky gut releases LPS into circulation; and from outside, through contaminated water — think sewer water and leaky sewer vents. Cholestyramine binds bile-associated LPS and interrupts its enterohepatic recycling, while gut work and probiotics address the internal source.

Beta-glucans. These fungal cell-wall fragments keep activating the immune system even after the mold that produced them is dead. They are not really “bound” by gut binders in a meaningful way; they are managed mostly by reducing exposure and calming the immune response — a useful reminder that not every biotoxin has a binder answer.

The Hidden Problem: Volatile and Semi-Volatile Organics

There is one more category that is both huge and easy to miss: volatile and semi-volatile organic compounds (VOCs and SVOCs). They come not only from mold — the musty “microbial VOCs” you can smell — but also from ordinary household sources: paints, floor finishes, new carpets and flooring, cabinetry and furniture, cleaning products and air fresheners, and the phthalates and flame retardants baked into plastics and textiles.²⁰ Many standard mold assessments never test for them at all, which is exactly why they stay hidden.

This also explains a counterintuitive point: moving into a brand-new home is not necessarily a safe reset for someone with CIRS. Fresh construction, new paint, new carpet, and new cabinetry can off-gas VOCs and SVOCs for months.

Binders help unevenly here, and this is important. Cholestyramine is not the answer for most volatile organics. Activated charcoal and certain zeolites adsorb many of them, and glutathione and the liver’s Phase II pathways are central to neutralizing them from the inside. In our experience, VOCs and SVOCs can keep a patient sick even after mold, actinomycetes, and endotoxins have all been accounted for — and the needle often does not move until these exposures are finally found and reduced.

How It All Began: A Tribute to Dr. Shoemaker

It would be wrong to write about binders without pausing to honor the physician who started it all. In 1980, Dr. Ritchie Shoemaker opened a small family practice in Pocomoke City, Maryland. In 1997, his patients began arriving with a baffling cluster of symptoms — diarrhea, headaches, brain fog, cough, and muscle aches — after exposure to the Pocomoke River. He traced the illness to Pfiesteria piscicida, a biotoxin-producing dinoflagellate then blooming in Chesapeake waters and killing billions of fish.

One of his patients, a young woman who fell ill after swimming in the river, was not responding to weeks of treatment. On a hunch, Dr. Shoemaker prescribed cholestyramine — a decades-old cholesterol medication — and something remarkable happened: not only did her diarrhea resolve, but her memory, headaches, cough, and muscle aches improved as well. That single observation — that a bile-acid binder could pull a biotoxin out of the body and lift an entire constellation of symptoms — became the seed of everything that followed. He published it as “Diagnosis of Pfiesteria–Human Illness Syndrome” in 1997 and spent the next decades building the field of biotoxin illness and CIRS: the Shoemaker Protocol, VCS testing, the HLA-DR genetics, and the use of cholestyramine and colesevelam as cornerstone binders.¹⁸

Nothing in this article is meant to contradict or replace his protocol — quite the opposite. Everything here is built on Dr. Shoemaker’s foundational work; we simply aim to expand the toolkit around it, adding gentler binders, combination strategies, drainage, and precision approaches for the patients who need them. Cholestyramine and its gentler cousin colesevelam (Welchol) remain central. Our goal is almost always to work them into the biotoxin journey at some point — and generally the sooner the better — always guided by what the patient can tolerate.

Why Cholestyramine Became the Gold Standard

Let’s begin with the binder that has received the most attention over the past two decades: cholestyramine.

Originally developed as a cholesterol-lowering medication, cholestyramine is a positively charged anion-exchange resin. Think of it as molecular Velcro. Its permanent positive charge allows it to grab negatively charged molecules that are secreted into bile and travel through the intestinal tract. That includes bile acids, ochratoxin A (OTA), PFAS (“forever chemicals”), certain persistent organic pollutants, some inflammatory lipids, and other compounds moving through enterohepatic circulation.

This is exactly why cholestyramine became the cornerstone of Dr. Ritchie Shoemaker’s original CIRS protocol. For patients with elevated OTA or significant exposure to persistent environmental chemicals such as PFAS, it remains one of the most effective tools we currently have. Colesevelam (Welchol) works by the same anion-exchange mechanism — generally gentler on the gut, though also somewhat weaker.

But Here’s the Catch

Not every mycotoxin behaves like ochratoxin A. This is where many discussions become oversimplified.

Some mycotoxins are strongly acidic and negatively charged. Others are essentially neutral. Some are highly fat soluble; others are relatively polar. Some undergo extensive enterohepatic recirculation; others appear to undergo very little. If a toxin doesn’t recycle through bile, a bile-acid sequestrant may not be nearly as effective. And if a toxin carries little negative charge, a positively charged resin will have much less affinity for it.

That doesn’t mean cholestyramine “doesn’t work.” It simply means it probably isn’t the entire answer.

There is also a very practical problem. Many of our sickest patients cannot tolerate cholestyramine at first. It commonly causes constipation, bloating, and reflux, and it can bind medications, thyroid hormone, and fat-soluble vitamins (A, D, E, K) if not separated by several hours. For someone who already struggles with constipation, mast cell activation, or autonomic dysfunction, four scoops of a potent bile-acid sequestrant on day one can make them miserable.

The Cholestyramine Paradox — and Why Patients Still Improve

Here is something that should give us all pause. The CIRS community treats cholestyramine as the binder of choice, yet the chemistry we just walked through shows that CSM has little affinity for a great many mycotoxins — aflatoxins, most trichothecenes, gliotoxin, and others. So why do so many patients clearly improve on it?

We think there are two answers. First, cholestyramine happens to be excellent at the toxins that matter most for the bile-recycling loop — ochratoxin A, PFAS, bile acids, and inflammatory or oxidized fats. Second, and probably more important, it is the single strongest interrupter of enterohepatic circulation we have. By breaking that reabsorption loop, it clears an entire class of bile-bound toxins at once — very likely including many that the research literature has not yet even characterized.

But the paradox cuts the other way too. Many patients do well at first and then stall — stuck on the Shoemaker protocol for many months or even years with no further progress. When that happens, it is usually a signal of one of two things: either exposure is ongoing, or the remaining burden is now dominated by mycotoxins and metals that cholestyramine simply does not bind well. That is precisely the moment when other binders — zeolite, clays, glucomannan, charcoal, humic and fulvic acids — earn their place. The answer to a stalled protocol is often not more cholestyramine, but a wider net.

A Practical Guide to Starting Cholestyramine

Because cholestyramine is powerful, how you take it matters as much as whether you take it. When we do use it, we coach patients through a few non-negotiables that make the difference between a smooth course and a miserable one.

We also track progress objectively — many patients repeat a monthly Visual Contrast Sensitivity (VCS) test — and we always pair binding with exposure control. None of this is a substitute for individualized guidance from your provider; ask our clinic for the full Cholestyramine Patient Guide if you would like the complete handout.

The Strongest Binder Isn’t Always the Best First Binder

This is one of the most important lessons in practice, and it mirrors the evolution seen in the work of clinicians like Dr. Neil Nathan. Many of our most sensitive patients arrive with some combination of methane-predominant SIBO (intestinal methanogen overgrowth), chronic constipation, mast cell activation syndrome (MCAS), autonomic and vagal dysfunction, and profound gastrointestinal sensitivity.

Giving these patients a strong prescription binder immediately often backfires. Does that mean cholestyramine is the wrong treatment? Not necessarily — it may simply be the wrong treatment at that stage of healing.

For these patients we frequently begin with gentler, better-tolerated options — products such as ZeoCharge®, Carboxy®, activated charcoal, bentonite clay, chlorella, Saccharomyces boulardii, or combination formulas like GI Detox® and Ultra Binder®. The goal is to start lowering the toxic burden while supporting bowel function and minimizing flares. As gut motility improves and the patient becomes more resilient, we gradually introduce colesevelam (Welchol) or cholestyramine when appropriate.

Classify Binders by Chemistry, Not Brand Name

In our opinion, binders should first be organized by how they work rather than by which company sells them. Once you see the underlying chemistry, the confusing landscape of competing products starts to make sense — and so does the rationale for combining them.

Think of this the way an infectious-disease physician thinks about antibiotics. You wouldn’t treat every infection with the single most powerful drug on the shelf. You match the agent to the organism, the tissue, and what the patient can tolerate. Binders deserve the same reasoning.

ZeoCharge: More Than a Heavy-Metal Binder

One of the products that consistently surprises people in our practice is ZeoCharge®, a purified clinoptilolite zeolite. Most clinicians think of zeolite simply as a heavy-metal binder — and to be fair, that is where much of its strongest evidence lies. Zeolites are negatively charged aluminosilicate minerals that excel at binding positively charged ions such as lead, cadmium, and ammonium. Human data support increased urinary excretion of several toxic metals with activated clinoptilolite.^5,6 (For more on heavy metals and mercury amalgam fillings, see our dental and chronic health video.)

But the chemistry doesn’t stop there. Because zeolites have a remarkable internal surface area and a microporous crystal structure, they can also adsorb certain organic compounds — including some mycotoxins — through hydrogen bonding and van der Waals forces rather than simple ion exchange. In other words, zeolite does grab mold toxins. It simply does so less powerfully than cholestyramine does for a strongly negatively charged toxin like ochratoxin A.

So we try to avoid two errors. The first is claiming zeolite is a high-affinity OTA binder equal to CSM — the chemistry doesn’t support that. The second, and more common, is dismissing it as “heavy metals only.” The feed-science and veterinary literature clearly shows clinoptilolite adsorbing aflatoxins and other mycotoxins, even if it is inconsistent for trichothecenes.^7,9

This is exactly why we find ZeoCharge such a useful global starting binder. Most mold-exposed patients don’t have just one toxin — they carry a mixture of heavy metals, mycotoxins, ammonium, histamine, and other burdens. A binder that addresses several of those at once, while being gentle on the gut, is a sensible place to begin, especially when GI issues are present. We frequently pair it with Carboxy® as a well-tolerated, broad-spectrum foundation, then layer in stronger prescription binders as the patient becomes ready.

Fulvic and Humic Acids: Broad-Spectrum Binders

Humic and fulvic acid blends such as Carboxy® deserve their own category. These compounds are chemically complex, carrying carboxyl groups, phenols, quinones, and aromatic rings that let them interact through ionic attraction, hydrogen bonding, hydrophobic interactions, metal chelation, and redox chemistry.

That versatility matters, because fulvic and humic acids are not just mold-toxin binders. Their diverse chemistry lets them engage a wide range of toxicants — heavy metals, pesticides and herbicides, and other environmental chemicals — which is exactly why they fit the “total toxic burden” picture we describe below. We view them less as simple “sponges” and more as biologically active detoxification-support compounds that may chelate some metals, support antioxidant defenses and gut-barrier integrity, and influence the microbiome. The strongest human data are still limited, but they are usually very well tolerated, which makes them valuable for sensitive patients and a natural complement to ZeoCharge early in a program.

Do fulvic and humic acids actually do anything at the cellular level, or do they just sit in the gut? It is a fair challenge — and the laboratory evidence is more substantial than most people realize. In human cell lines and animal models, fulvic and humic acids show real biological activity. They lower inflammatory signaling (reducing TNF-α, COX-2, and NF-κB activation),²² they stabilize mast cells and reduce histamine release — even lowering intracellular calcium, which is directly relevant to the mast cell activation so many mold patients struggle with²³ — they scavenge reactive oxygen species as antioxidants,²⁵ and they even interfere with the tau-protein aggregation implicated in neurodegeneration.²⁴ Chemically, their many reactive functional groups let them bind an unusually broad range of toxins: heavy metals, pesticides and glyphosate, and even PFAS.^26,27 And formal toxicology work places their safety margin very high, with no adverse effects in animals even at large doses.²¹

Not every humic/fulvic product is equally strong. For very sensitive patients, an even gentler carbon-and-fulvic option such as CellCore’s Biotoxin Binder can be a useful starting point — it is generally not as potent as Carboxy, but some patients need to begin there and work up as tolerance improves.

Why We So Often Combine Binders

If you’ve ever wondered why one practitioner recommends charcoal, another recommends zeolite, and a third swears by glucomannan — they may all be partly right. They’re simply targeting different chemistry.

Instead of asking “What is the best binder?”, the more useful question becomes: “What combination of chemistries best covers this patient’s toxin profile while staying tolerable?”

Three More Binders Worth Knowing

Glucomannan — the underappreciated one

Modified glucomannan, derived from the cell wall of Saccharomyces cerevisiae yeast, is one of the most overlooked binders in human environmental medicine — largely because most of its evidence lives in the veterinary and feed-science literature. There it is impressive. Esterified glucomannan has bound roughly 75–90% of aflatoxin in vitro and meaningfully protected animals from aflatoxin, zearalenone, and several Fusarium toxins. It works not through charge but through hydrogen bonding, molecular fit, and hydrophobic interaction, which is why it can grab neutral toxins that anion-exchange resins largely miss. It is also very well tolerated, which makes it a useful addition for patients who need broader coverage.

Chitosan — a positively charged fiber

Chitosan is a cationic polysaccharide made from the shells of crustaceans. Its positive charge lets it bind dietary fats and bile, along with some heavy metals, PFAS, and certain mycotoxins. Because it reduces fat absorption, timing and dosing matter, and anyone with a shellfish allergy should avoid it. We think of chitosan as a niche tool rather than a first-line binder — useful in specific situations, particularly where fat-soluble toxin recycling and lipid handling overlap.

MegaSpore® and spore-based probiotics

This may be the most surprising entry on the list. Spore-based probiotics such as MegaSpore® (a blend of Bacillus strains) are not “binders” in the classic adsorptive sense, yet they earn a place in the conversation for two reasons. First, certain probiotic strains can physically bind or biologically transform a range of mycotoxins in the gut — which is why “probiotics” light up across so many rows on binder charts. Second, and arguably more important, they strengthen the intestinal barrier, help calm endotoxin (LPS) load, and support healthier bile flow and motility. In other words, they help the terrain that determines whether every other binder can do its job. We frequently use them alongside binders rather than instead of them.

If We Had to Pick Just Two for Mold

Patients often ask us to cut through the complexity: if you could only use two binders for mold, which would they be? Our honest answer is cholestyramine and activated charcoal.

Cholestyramine brings the deepest evidence base and unmatched strength for the negatively charged, bile-recycled toxins — especially ochratoxin A — along with real human data for PFAS and endotoxin. Activated charcoal brings the opposite virtue: enormous, charge-indifferent surface area that adsorbs a broad sweep of organic mold toxins, bacterial metabolites, and other compounds that a charge-based resin would ignore. One is a precision instrument; the other is a wide net. Together they cover far more ground than either alone.

That said, “the best two” is not the same as “the best two to start with.” As we discussed above, many patients need a gentler on-ramp — ZeoCharge®, Carboxy®, clays, or glucomannan — before their gut and nervous system can tolerate cholestyramine or high-dose charcoal. And the precision chart makes the deeper point: because no single binder tops every column, the strongest real-world strategy is usually a tolerable combination rather than a single “winner.”

The Expanding List of Mold Toxins We Test For

Early binder discussions tended to focus on just a handful of mycotoxins. Modern serum (IgG/IgE) and urine panels are far broader. The serum antibody panel we often use in clinic, for example, screens up to fourteen mold-related markers — and each behaves differently, which is exactly why binder selection has to be individualized.

Different labs and panels cover different toxins — urine panels frequently add aflatoxins, citrinin, enniatins, and others. The point is not to memorize the list but to appreciate the diversity: with this many chemically distinct toxins in play, no single binder could possibly be ideal for all of them.

A Precision Biotoxin & Binder Chart

Binary “X” charts that simply mark whether a binder touches a toxin hide the most useful information: how strongly it binds. Below is a more granular version. Each cell rates the relative binding capacity of a binder for a specific biotoxin — mycotoxins plus the actinomycetes, endotoxins, beta-glucans, and organic compounds discussed above — on a five-star scale, drawing on in-vitro data, the veterinary and feed-science literature, and clinical experience.

How to read it: ★★★★★ = strongest, best-supported binding for that toxin · ★★★ = moderate · ★☆☆☆☆ = weak but plausible · n/a = little or no meaningful data. A blank or low rating usually means the binder hasn’t been well studied for that toxin — not that it has been proven useless.

Why Does ART Sometimes Choose Binders You Wouldn’t Expect?

In our clinic we use Autonomic Response Testing (ART) as one component of individualized decision-making. One of the interesting observations over the years is that ART frequently selects binders such as ZeoCharge® and Carboxy® early in treatment — even when laboratory chemistry might predict a different “strongest” binder for a given toxin.

We don’t interpret this to mean those products are the highest-affinity binders for every mycotoxin. Laboratory science asks, “What binds toxin X?” ART, as we use it, is really asking a different question: “What does this patient’s system appear able to tolerate and benefit from today?” Bowel function, inflammatory load, mast cell status, heavy-metal burden, and overall resilience all shape that answer — not affinity for OTA alone.

Is There Really “No Evidence” for Binders?

It is worth engaging a criticism you will hear from some physicians: that there is no medical literature supporting the use of binders, and that the whole approach is unproven. It’s a claim worth taking seriously rather than dismissing.

The strongest version of that argument is fair: we do not yet have large, randomized, placebo-controlled human trials showing that binders cure mold illness or CIRS. A great deal of the supporting data comes from veterinary and feed-science research, from in-vitro binding studies, and from clinical observation rather than from gold-standard human trials. Anyone claiming binders are definitively “proven” for every mold toxin is overstating the case.

But “no large human RCT” is not the same as “no evidence” — and the flat claim that there is no literature simply isn’t accurate. Cholestyramine has controlled animal data for ochratoxin A, human crossover-trial data for PFAS, and mechanistic data for reducing endotoxin. Clinoptilolite has human data for heavy-metal excretion. Glucomannan, clays, and zeolite have substantial in-vitro and animal binding data. And bile-acid sequestrants have decades of documented clinical use dating back to Dr. Shoemaker’s original CIRS work. The absence of a definitive trial usually reflects how hard and unfunded such studies are to run — not proof that the intervention fails.

So we try to hold both truths at once. We are honest about where the human evidence is still thin, and we don’t oversell. At the same time, we have watched patients improve consistently with individualized binder therapy over many years. Clinical experience is not the top of the evidence hierarchy, but it is not nothing — especially when it lines up with plausible chemistry and the data we do have.

It’s Not Just Mold: The Bigger Picture of Total Toxic Burden

Focusing only on mold can miss the larger story. Most of us now carry a lifelong, cumulative load of environmental exposures — pesticides and herbicides, plastics and phthalates, PFAS “forever chemicals”, heavy metals, air pollution, and countless synthetic compounds. One reasonable theory is that this chronic background burden gradually overwhelms and weakens our detoxification pathways, so that by the time mold enters the picture, it is less the whole disease than the tipping point — the icing on the cake that pushes an already-taxed system into overt illness.

This reframes what binders are actually for. They are not merely “mold removers.” Used thoughtfully, they help lower the total toxic burden — which is one more reason we lean toward broad-spectrum, well-tolerated binders early, and why a patient’s response often tracks with their whole exposure history rather than a single urine mycotoxin value.

When Heavy Metals and Mold Collide

Mold rarely travels alone. In our experience, heavy metals — frequently from retained mercury amalgam fillings — often complicate a mold-detox journey. We suspect a deeper mechanism at work: heavy metals appear to help reactivate latent viruses such as the herpes-family viruses and Epstein–Barr. That adds pressure to an already overloaded immune system and creates a kind of immune confusion that can keep patients stuck no matter how well the mold piece is being handled. (For more on amalgams and metals, see our dental and chronic health video.)

Practically, this means a patient carrying both metals and mold usually needs more than cholestyramine alone. CSM does little for heavy metals, so we pair it with a metal-capable binder such as zeolite/ZeoCharge® — and sometimes modified citrus pectin (PectaSol®) or humic and fulvic compounds — so both burdens are addressed together.

Sequencing is where it gets subtle. Sometimes the body clearly wants metals cleared first; sometimes it wants mold addressed first. There is no universal order that fits everyone, which is one more reason we lean on ART to read what a given patient’s system seems to be prioritizing at a given moment.

Gut Binders vs. Cellular Detox: Two Different Jobs

Here is a distinction that changes how you think about the whole process. Most binders — cholestyramine, clays, and activated charcoal among them — work only in the gut. They capture toxins traveling through bile and the intestine, which is enormously valuable, but they never enter your cells. Mycotoxins, however, do much of their damage inside the cell — disrupting mitochondria, cell membranes, and even DNA. A binder sitting in the gut simply cannot reach a toxin lodged deep in a cell.

This is one reason we value tools designed to work at the cellular level. CellCore’s Carboxy® and Biotoxin Binder use fulvic/humic and carbon-based chemistry intended to reach the intracellular environment rather than staying in the gut. Certain water-soluble and liposomal zeolites — such as ClearDrops and ClearDrops Pro (available through our shop) — are formulated to cross cell membranes and support systemic, cellular-level detoxification.

The Biofilm Problem: A Hidden Reason Patients Stall

There is one more piece that almost no binder article mentions: biofilms. Many bacteria and molds secrete a biofilm — a protective, slime-like matrix that shields them from the outside world. That matrix does not just hide the organism; it physically blocks binders from reaching the toxins within, and it keeps antifungals and antibiotics from penetrating as well.^14,15 You can be doing everything right and still stall, because the target is walled off.

We increasingly believe biofilms are one of the fundamental reasons patients get stuck on the Shoemaker protocol despite months or years of effort. Timing matters: we usually do not go after biofilms in the first phase of a detox — it can stir up too much at once — but somewhere in the middle-to-later phases, addressing them often becomes the key that gets a stalled patient moving again.

The encouraging news is that we now have several advanced biofilm strategies, and we have seen them succeed. To name a few: AquaLaurin is an advanced liposomal monolaurin that can reach many fungal species in a way reminiscent of a prescription antifungal — in our experience the AquaLaurin Citrus version seems to work especially well for mold and biotoxins, although this remains clinical observation rather than proven fact, and timing again matters. Another uniquely versatile option is PectaSol® (a modified citrus pectin), which we value for a rare triple role — helping to disrupt biofilms, gently binding heavy metals, and potentially assisting with mold toxins as well (available through our shop). Others we use include Biofilm Phase-2 and Novalytic, which we will cover in future articles.

Two caveats worth flagging. First, since COVID we suspect that certain man-made hydrogels may make some biofilms even harder to penetrate — a complex and still-unproven topic we explore separately. Second, if genuine spike-protein persistence is part of your picture, it can complicate a mold-detox journey in its own right. For both, see our article When the Spike Won’t Let Go; we will publish more on spike-protein detoxification in the future.

Don’t Forget the Gut

Binders cannot do their job if the terrain they pass through isn’t working. If a patient is constipated, dehydrated, has sluggish bile flow, methane or hydrogen overgrowth, vagal dysfunction, or active mast cell activation, even the “perfect” binder may fail — or make things worse.

A common culprit is small intestinal bacterial overgrowth (SIBO) — which we frequently find is itself driven by mold, or left behind by a bout of post-infectious IBS. When SIBO is present, especially alongside constipation, patients often simply cannot tolerate cholestyramine at the outset; dropping a potent bile-acid sequestrant onto an overgrown, sluggish gut tends to amplify bloating, discomfort, and constipation. This is a big part of why we usually do not start with cholestyramine. We work on that underlying gut layer first — addressing the SIBO, motility, and bile flow — then layer in gentler binders as tolerance improves, and finally introduce cholestyramine once the gut is ready to accept it.

This is why so much of our early work focuses on motility, hydration, bile flow, and calming an overreactive nervous system before escalating binder strength. Supporting the gut first is often what allows a patient to eventually tolerate cholestyramine at all.

Why do some patients feel worse when they start binders?

Patients often interpret an early flare as “this binder is harming me.” Usually the real explanation is one of a few things: mobilization of stored toxins, interruption of enterohepatic recirculation, worsening constipation, mast cell activation, shifts in bile-acid metabolism, or simply starting too aggressively. Understanding this — and adjusting the dose downward rather than quitting — is often the difference between success and abandonment. Once again: low and slow tends to win.

Binders Are Only One Part of the Detox Strategy

Here is a point that gets far too little attention: a binder can only remove what actually reaches the gut. Toxins mobilized from tissues have to travel out through the body’s drainage routes — bile and bowels, kidneys, sweat, and the lymphatic system — before a binder in the intestine can escort them out. If those pathways are congested, mobilized toxins simply recirculate, and patients often feel worse.

That is why we treat binders as one piece of a larger detoxification strategy rather than the whole plan. Alongside them we work on drainage and lymphatic support (hydration, regular bowel movements, daily movement, dry brushing, castor oil packs, rebounding), sweating — particularly through infrared sauna, one of the most useful ways to mobilize and excrete fat-soluble toxins — and foundational diet and lifestyle measures such as a clean, anti-inflammatory diet, blood-sugar balance, sleep, stress and vagal-tone work, and adequate protein for the liver’s own detox pathways. For some patients we also discuss coffee enemas.

We are transparent that the published evidence for several of these drainage practices is limited, and that coffee enemas in particular carry real risks if done improperly and are not right for everyone. But in our clinical experience, most patients feel meaningfully better when binders are combined with drainage and lifestyle support rather than used alone. For a deeper walk-through, see our successful detox protocols article and video.

Phosphatidylcholine: Protecting Membranes While You Bind

If you are going to use a bile-acid sequestrant like cholestyramine, it is best practice to support your cell membranes at some point in the journey — ideally sooner rather than later. Here is the concern: cholestyramine works by stripping bile and interrupting enterohepatic recirculation, and over time that same action can draw down your fatty-acid and phospholipid reserves. Yet those phospholipids are exactly what the body needs to rebuild cell membranes while it detoxifies. This is where phosphatidylcholine (PC) comes in. To be clear, PC is not a binder; it supports the membrane and cellular side of detoxification.

Rather than physically trapping toxins in the gut the way an ion-exchange resin does, PC appears to work by improving lipid transport, membrane turnover, lipoprotein formation, bile composition, and the liver’s export of fat-soluble compounds.²⁸ In the membrane-medicine tradition of clinicians such as Patricia Kane and Vosloo, PC may help the body package and offload a lifetime of lipophilic environmental toxicants — persistent organic pollutants, PCBs, dioxins, organochlorine pesticides and herbicides, phthalates, BPA, microplastic-associated chemicals, possibly some heavy metals, and some mycotoxins. In other words, it may help mobilize and transport toxins rather than bind them.

Some argue that binders “force” the system to detox and that PC is the gentler path. Our experience is different: in genuine mold and biotoxin illness, binders remain paramount — especially one that interrupts enterohepatic circulation, like cholestyramine. But PC and binders are complementary, not competing. The key question is what happens to a toxin once PC helps mobilize it: if it enters the bile, much of it can be reabsorbed unless something captures it in the gut. That is precisely where the two become synergistic:

• PC mobilizes toxins, repairs membranes, and improves bile flow and transport.
• Binders capture what reaches the intestine so it is not reabsorbed.
• The liver and kidneys metabolize and eliminate the rest.

This is why, when we mobilize with PC, we keep binders on board. There is also an intriguing possibility worth sitting with: for some patients, mold may not have been the original problem so much as the tipping point — the final insult on top of decades of accumulated environmental toxins that had already weakened the terrain. If PC helps lift that background burden, the immune system may become more capable of finally clearing the mold. Not every “mold patient,” after all, is primarily a mold patient.

A fair word on evidence. Financial incentives exist throughout functional medicine — advisory boards, honoraria, affiliate relationships, and in-practice supplement sales — but they do not automatically invalidate anyone’s clinical observations; we simply weigh the evidence on its own merits. On objective, measurable endpoints — VCS, inflammatory biomarkers, HLA stratification, NeuroQuant, and GENIE gene-expression — the Shoemaker binder-based model still stands out, whereas PC has strong biologic plausibility and many anecdotal successes but less published evidence of normalizing those markers on its own. The most defensible position is not “PC fixes everything” or “cholestyramine fixes everything” — it is that they are complementary, likely occupying different phases of recovery. We will publish a fuller deep-dive on PC (and related lipid strategies such as plasmalogens and the Shoemaker VIP step) in a future article.

Glutathione: The Body’s Master Detoxifier

Gut binders are only part of the story. The body has its own internal detoxification system, and glutathione sits at its center. Through glutathione-S-transferase enzymes, glutathione conjugates — in effect, binds — reactive toxins, including the reactive epoxide that aflatoxin forms, neutralizing them and making them water-soluble for excretion.¹¹ In that sense glutathione is an internal binder, working at the cellular level rather than in the gut, and it is a critical part of any complete mold-detox strategy.

The catch is supply. We make a little less glutathione each year as we age, and the chronic toxic and inflammatory load of mold illness depletes it further — which is why so many of these patients run low. Replacing it is not straightforward, because ordinary oral glutathione is poorly absorbed. We tend to favor liposomal glutathione and glutathione suppositories for that reason. If you would like to discuss whether either fits your plan, please reach out to our clinic.

Polyphenols and Protecting the Kidneys

Binders and glutathione mostly address the liver–bile–gut route of elimination. But mold toxins also leave the body through the kidneys, and that pathway needs protection too. Naturopathic mold expert Dr. Jill Crista has emphasized a “bioflavonoids before binders” approach — using polyphenols and bioflavonoids such as quercetin to support the kidneys’ ability to clear mycotoxins and to shield organs from oxidative damage.¹³

We share that view and use polyphenols in our own practice, both as gentle adjuncts that lower oxidative stress and support drainage, and in some cases as mild binders in their own right. They pair naturally with the fulvic and humic acids and the broader drainage strategy described above — another reminder that detoxification is a team effort, not a single product.

Should We All Be Taking Binders?

It is a fair question to end on. Our short answer is a qualified yes — at least gentle, long-term binders — and not only for people with diagnosed mold illness.

Every one of us now carries a rising background load of modern toxicants, whether or not we have ever set foot in a water-damaged building: microplastics, PFAS “forever chemicals,” and a long list of environmental compounds. Taken consistently and gently, everyday binders such as Biotoxin Binder, Carboxy®, chlorella, and even MegaSpore® can quietly chip away at that ongoing load.

There is also a preventive case where mold is concerned. Many homes harbor at least some mold without anyone realizing it. Even below the threshold of obvious symptoms, low-level exposure can generate oxidative stress that accumulates over many years. Mold and mycotoxins are associated with immune dysregulation and autoimmunity, and some mycotoxins — aflatoxin among them — are established human carcinogens.¹⁶ Researchers continue to investigate possible links between chronic biotoxin exposure and neurodegenerative conditions such as multiple sclerosis and Parkinson’s. We cannot claim that binders prevent any of these diseases — that has not been shown — but steadily lowering the toxic and oxidative burden is a reasonable, low-risk form of prevention.

A few caveats. For prevention, binders should be gentle and low-dose, taken with attention to daily bowel movements and spaced away from food, medications, and nutrients. They are never a substitute for fixing the home or for proper medical evaluation, and the specifics should be individualized with your provider. But as one piece of a modern, toxin-aware life, we think a thoughtful, gentle binder has a place for almost everyone.

Frequently Asked Questions

Related Reading & Resources

To go deeper on the topics touched on here, explore these resources from our clinic:

• Understanding Autonomic Response Technique (ART) — how we use biofeedback muscle testing to help individualize binder and remedy selection.
• Successful Detox Protocols (article + video) — how binders fit within a complete detoxification strategy.
• Mold Illness & CIRS (video) — an overview of biotoxin illness and the Shoemaker framework.
• Dental & Chronic Health Challenges (video) — heavy metals, mercury amalgams, and their role in chronic illness.
• Precision Mycotoxin Detoxification — Episode #122 with Beth O’Hara FN, Emily Givler DSC, and Neil Nathan MD (video) — a detailed practitioner discussion of precision binder strategy.
• Shop practitioner-grade binders: Carboxy®, ZeoCharge®, Biotoxin Binder, and MegaSpore® at our online store.
• OligoScan — Advanced Cellular Analysis — how we monitor minerals, heavy metals, and fat-soluble vitamin status at the tissue level.
• When the Spike Won’t Let Go — spike-protein persistence, biofilms, and how they complicate detox.
• AquaLaurin™ for Biofilm Disruption — our write-up on liposomal monolaurin for biofilms; and cellular-detox zeolites (ClearDrops) at our detox shop.
• Actinomycetes, CIRS & Biotoxin Illness — the bacteria in water-damaged buildings that can be more inflammatory than mold.
• Chronic Inflammatory Response Syndrome (CIRS) — an overview of biotoxin illness and how we approach it.
• Browse all of our educational articles.